secwatch / observer
8-K filed November 1, 2022, 7:59 PM ET ticker HSIC CIK 0001000228
earnings confidence high sentiment positive materiality 0.75

Henry Schein reports record Q3 non-GAAP diluted EPS of $1.15; narrows FY2022 guidance

HENRY SCHEIN INC

2022-Q3 EPS reported $3.55 revenue$9,276,000,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

HENRY SCHEIN INC reported the nine months ended September 24, 2022 results: revenue $9.3 billion, net income $491 million, EPS $3.55. Guidance reaffirmed.

Period
the nine months ended September 24, 2022
Revenue
$9.3 billion
Net income
$491 million
EPS
$3.55
Guidance
reaffirmed
Result
reported results
Exact text from the filing
Total net sales for the first nine months of 2022 were $9.3 billion, an increase of 2.3% compared with the first nine months of 2021. The 2.3% increase included 2.4% internal growth in local currencies excluding acquisitions and 2.1% growth from acquisitions, offset by a 2.2% decrease related to foreign currency exchange. Sales of PPE and COVID-19 test kits for the first nine months were $991 million, which is $344 million lower than in the prior-year period. When excluding sales of PPE and COVID-19 test kits, our internal sales growth for the first nine months of 2022 in local currencies was 7.3% compared with the prior-year period. ● GAAP net income for the first nine months of 2022 was $491 million, or $3.55 per diluted share, compared with GAAP net income for the first nine months of 2021 of $484 million, or $3.40 per diluted share.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

HENRY SCHEIN INC reported the three months ended September 24, 2022 results: revenue $3.1 billion, net income $150 million, EPS $1.09. Guidance reaffirmed.

Period
the three months ended September 24, 2022
Revenue
$3.1 billion
Net income
$150 million
EPS
$1.09
Guidance
reaffirmed
Result
reported results
Exact text from the filing
Total net sales for the quarter were $3.1 billion, a decrease of 3.5% compared with the third quarter of 2021. The 3.5% decrease included a 2.4% decrease in local currencies excluding acquisitions, 1.8% growth from acquisitions and a 2.9% decrease related to foreign currency exchange 1 . Sales of PPE and COVID-19 test kits in the third quarter were $244 million, which is $260 million lower than the prior-year period. When excluding sales of PPE and COVID-19 test kits, our third-quarter internal sales growth in local currencies was 6.8% compared with the prior- year period. ● GAAP net income for the quarter was $150 million, or $1.09 per diluted share, compared with third-quarter 2021 GAAP net income of $162 million, or $1.15 per diluted share.
View on SEC.gov

Browse all earnings releases →

HENRY SCHEIN INC filing history →

Source: SEC EDGAR
accession 0001000228-22-000066
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.